DocMorris AG Net Assets

Latest as of June 2025: CHF480.35 Million CHF ≈ $607.29 Million USD

DocMorris AG net assets. Based on the latest financial reports, DocMorris AG (DOCM) has net assets worth CHF480.35 Million CHF (≈ $607.29 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF907.44 Million ≈ $1.15 Billion USD) and total liabilities (CHF427.09 Million ≈ $539.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore DocMorris AG equity growth rate to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CHF480.35 Million
% of Total Assets	52.93%
Annual Growth Rate	9.26%
5-Year Change	-36.04%
10-Year Change	367.34%
Growth Volatility	49.88

Net Assets of DocMorris AG (2009–2024)

Net assets of DocMorris AG from 2009 to 2024. This chart illustrates how DocMorris AG's net assets have evolved over time, based on quarterly financial data. See DocMorris AG (DOCM) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Net Assets for DocMorris AG (2009–2024)

The table below shows the annual net assets of DocMorris AG from 2009 to 2024. For live market cap and overall valuation, see DOCM market cap overview.

Year	Net Assets	Change
2024-12-31	CHF340.11 Million ≈ $430.00 Million	-21.00%
2023-12-31	CHF430.53 Million ≈ $544.31 Million	+22.74%
2022-12-31	CHF350.78 Million ≈ $443.48 Million	-27.66%
2021-12-31	CHF484.92 Million ≈ $613.07 Million	-8.80%
2020-12-31	CHF531.74 Million ≈ $672.26 Million	+31.12%
2019-12-31	CHF405.54 Million ≈ $512.71 Million	-8.58%
2018-12-31	CHF443.61 Million ≈ $560.84 Million	+50.77%
2017-12-31	CHF294.22 Million ≈ $371.98 Million	+183.44%
2016-12-31	CHF103.81 Million ≈ $131.24 Million	+42.64%
2015-12-31	CHF72.78 Million ≈ $92.01 Million	-5.91%
2014-12-31	CHF77.35 Million ≈ $97.79 Million	+5.41%
2013-12-31	CHF73.38 Million ≈ $92.77 Million	-14.47%
2012-12-31	CHF85.79 Million ≈ $108.46 Million	+4.88%
2011-12-31	CHF81.80 Million ≈ $103.42 Million	+3.29%
2010-12-31	CHF79.19 Million ≈ $100.12 Million	-12.14%
2009-12-31	CHF90.14 Million ≈ $113.96 Million	--

Equity Component Analysis

This analysis shows how different components contribute to DocMorris AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1689.9% over the analyzed period, potentially due to dividend distributions or operating losses.

DocMorris AG Net Assets Breakdown (December 2024)

DocMorris AG net assets breakdown by equity component as of December 2024.

Component	Amount	Percentage
Common Stock	CHF445.05 Million	130.85%
Other Comprehensive Income	CHF582.55 Million	171.28%
Total Equity	CHF340.11 Million	100.00%

DocMorris AG Competitors by Market Cap

The table below lists competitors of DocMorris AG ranked by their market capitalization.

Company	Market Cap
Top Gum Industries Ltd TA:TPGM	$281.95 Million
Socep Constant RO:SOCP	$282.03 Million
Jiangsu Feiliks Intl Logistics SHE:300240	$282.19 Million
Ajmera Realty & Infra India Limited NSE:AJMERA	$282.19 Million
Trailblazer Acquisition Corp. Class A Ordinary Shares NASDAQ:BLZR	$281.88 Million
Hospital Mater Dei S.A SA:MATD3	$281.86 Million
First United Corporation NASDAQ:FUNC	$281.84 Million
HannsTouch Solution Inc TW:3049	$281.74 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in DocMorris AG's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 430,532,000 to 340,114,000, a change of -90,418,000 (-21.0%).
Net loss of 97,253,000 reduced equity.
Share repurchases of 73,000 reduced equity.
Other comprehensive income increased equity by 2,621,000.
Other factors increased equity by 4,287,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CHF-97.25 Million	-28.59%
Share Repurchases	CHF73.00K	-0.02%
Other Comprehensive Income	CHF2.62 Million	+0.77%
Other Changes	CHF4.29 Million	+1.26%
Total Change	CHF-	-21.00%

Book Value vs Market Value Analysis

This analysis compares DocMorris AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.53x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.88x to 0.53x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	CHF17.46	CHF15.32	x
2011-12-31	CHF25.67	CHF15.32	x
2012-12-31	CHF26.85	CHF15.32	x
2013-12-31	CHF21.68	CHF15.32	x
2014-12-31	CHF22.86	CHF15.32	x
2015-12-31	CHF21.44	CHF15.32	x
2016-12-31	CHF22.89	CHF15.32	x
2017-12-31	CHF56.35	CHF15.32	x
2018-12-31	CHF69.87	CHF15.32	x
2019-12-31	CHF46.82	CHF15.32	x
2020-12-31	CHF58.58	CHF15.32	x
2021-12-31	CHF50.28	CHF15.32	x
2022-12-31	CHF32.55	CHF15.32	x
2023-12-31	CHF36.88	CHF15.32	x
2024-12-31	CHF28.84	CHF15.32	x

Capital Efficiency Dashboard

This dashboard shows how efficiently DocMorris AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -28.59%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -9.56%
• Asset Turnover: 1.31x
• Equity Multiplier: 2.29x
Recent ROE (-28.59%) is below the historical average (-10.73%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	4.95%	0.80%	3.36x	1.83x	CHF-4.00 Million
2011	10.60%	1.78%	3.37x	1.77x	CHF494.00K
2012	7.18%	1.18%	1.97x	3.10x	CHF-2.42 Million
2013	-21.07%	-1.70%	4.05x	3.07x	CHF-22.80 Million
2014	9.25%	0.78%	4.01x	2.95x	CHF-581.10K
2015	4.73%	0.41%	3.57x	3.21x	CHF-3.83 Million
2016	-12.30%	-1.45%	3.36x	2.52x	CHF-23.15 Million
2017	-12.33%	-3.69%	2.15x	1.55x	CHF-65.64 Million
2018	-8.79%	-3.23%	1.66x	1.64x	CHF-83.33 Million
2019	-12.91%	-3.86%	1.37x	2.44x	CHF-92.92 Million
2020	-25.52%	-9.19%	1.16x	2.40x	CHF-188.87 Million
2021	-46.55%	-13.07%	1.36x	2.62x	CHF-274.23 Million
2022	-48.78%	-18.38%	0.85x	3.13x	CHF-206.19 Million
2023	19.11%	8.49%	1.12x	2.01x	CHF39.23 Million
2024	-28.59%	-9.56%	1.31x	2.29x	CHF-131.26 Million

Industry Comparison

This section compares DocMorris AG's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

No peer company data available for comparison.

About DocMorris AG

SW:DOCM Switzerland Pharmaceutical Retailers

Market Cap

$941.30 Million

CHF744.54 Million CHF

Market Cap Rank

#14824 Global

#161 in Switzerland

Share Price

CHF15.32

Change (1 day)

-4.43%

52-Week Range

CHF3.98 - CHF16.08

All Time High

CHF509.00